195 related articles for article (PubMed ID: 27892497)
1. Optimising Antibiotic Usage to Treat Bacterial Infections.
Paterson IK; Hoyle A; Ochoa G; Baker-Austin C; Taylor NG
Sci Rep; 2016 Nov; 6():37853. PubMed ID: 27892497
[TBL] [Abstract][Full Text] [Related]
2. Multi-objective evolutionary design of antibiotic treatments.
Ochoa G; Christie LA; Brownlee AE; Hoyle A
Artif Intell Med; 2020 Jan; 102():101759. PubMed ID: 31980097
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary optimisation of antibiotic dosing regimens for bacteria with different levels of resistance.
Goranova M; Ochoa G; Maier P; Hoyle A
Artif Intell Med; 2022 Nov; 133():102405. PubMed ID: 36328666
[TBL] [Abstract][Full Text] [Related]
4. Optimising efficacy of antibiotics against systemic infection by varying dosage quantities and times.
Hoyle A; Cairns D; Paterson I; McMillan S; Ochoa G; Desbois AP
PLoS Comput Biol; 2020 Aug; 16(8):e1008037. PubMed ID: 32745111
[TBL] [Abstract][Full Text] [Related]
5. Mathematical model predicts anti-adhesion-antibiotic-debridement combination therapies can clear an antibiotic resistant infection.
Roberts PA; Huebinger RM; Keen E; Krachler AM; Jabbari S
PLoS Comput Biol; 2019 Jul; 15(7):e1007211. PubMed ID: 31335907
[TBL] [Abstract][Full Text] [Related]
6. Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens.
Igler C; Rolff J; Regoes R
Elife; 2021 May; 10():. PubMed ID: 34001313
[TBL] [Abstract][Full Text] [Related]
7. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
8. Modeling the influence of non-adherence on antibiotic efficacy: application to ciprofloxacin.
Lansky P; Sanda P; Weiss M
Int J Clin Pharmacol Ther; 2007 Aug; 45(8):438-47. PubMed ID: 17725177
[TBL] [Abstract][Full Text] [Related]
9. Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations.
Brill MJE; Kristoffersson AN; Zhao C; Nielsen EI; Friberg LE
Clin Microbiol Infect; 2018 Jul; 24(7):697-706. PubMed ID: 29229429
[TBL] [Abstract][Full Text] [Related]
10. Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.
Ankomah P; Levin BR
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8331-8. PubMed ID: 24843148
[TBL] [Abstract][Full Text] [Related]
11. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
[TBL] [Abstract][Full Text] [Related]
12. A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria.
Slama TG; Amin A; Brunton SA; File TM; Milkovich G; Rodvold KA; Sahm DF; Varon J; Weiland D;
Am J Med; 2005 Jul; 118 Suppl 7A():1S-6S. PubMed ID: 15993671
[TBL] [Abstract][Full Text] [Related]
13. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
Lieberman JM
Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
[TBL] [Abstract][Full Text] [Related]
14. [Proper antibiotic therapy. From penicillin to pharmacogenomic].
Caramia G; Ruffini E
Minerva Pediatr; 2012 Apr; 64(2):225-37. PubMed ID: 22495196
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome.
Spanu T; Santangelo R; Andreotti F; Cascio GL; Velardi G; Fadda G
Int J Antimicrob Agents; 2004 Feb; 23(2):120-8. PubMed ID: 15013036
[TBL] [Abstract][Full Text] [Related]
16. Phagocytes, Antibiotics, and Self-Limiting Bacterial Infections.
Levin BR; Baquero F; Ankomah PP; McCall IC
Trends Microbiol; 2017 Nov; 25(11):878-892. PubMed ID: 28843668
[TBL] [Abstract][Full Text] [Related]
17. When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition.
Pena-Miller R; Laehnemann D; Jansen G; Fuentes-Hernandez A; Rosenstiel P; Schulenburg H; Beardmore R
PLoS Biol; 2013; 11(4):e1001540. PubMed ID: 23630452
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.
Regoes RR; Wiuff C; Zappala RM; Garner KN; Baquero F; Levin BR
Antimicrob Agents Chemother; 2004 Oct; 48(10):3670-6. PubMed ID: 15388418
[TBL] [Abstract][Full Text] [Related]
19. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
20. Newly approved antibiotics and antibiotics reserved for resistant infections: Implications for emergency medicine.
Mazer-Amirshahi M; Pourmand A; May L
Am J Emerg Med; 2017 Jan; 35(1):154-158. PubMed ID: 28029487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
